Gemer Sita Ir 50/500/2 Tablet 10

Gemer Sita Ir 50/500/2 Tablet 10 may interact with other medicines, such as:

• Antihypertensive medicines (e.g., enalapril, atenolol): Some antihypertensive medicines (especially beta-blockers) may mask symptoms of hypoglycaemia or affect blood sugar levels. Close monitoring of blood glucose levels may be required, especially when starting or adjusting therapy.
• Antidiabetic medicines (e.g., insulin): Concomitant use with other blood sugar-lowering medicines may significantly increase the risk of hypoglycaemia. Dose adjustment and careful monitoring are important to avoid sudden drops in blood glucose levels.
• Antitubercular medicines (e.g., rifampicin): These medicines may reduce the effectiveness of sitagliptin and glimepiride by increasing their metabolism, leading to poor blood sugar control. Monitoring and dose adjustment may be required.
• Antiepileptic medicines (e.g., phenytoin): These medicines may alter blood sugar levels and reduce the effectiveness of this combination. Regular monitoring of glucose levels is recommended.
• Corticosteroids (e.g., prednisolone): May increase blood glucose levels and reduce the effectiveness of this medicine by promoting insulin resistance. Blood sugar monitoring and dose adjustment may be necessary.
• Diuretics (e.g., furosemide, hydrochlorothiazide): May impair blood glucose control and affect kidney function, which can influence the clearance of metformin and sitagliptin. Monitoring is advised.
• Cimetidine and other medicines affecting renal function: May reduce the clearance of metformin, increasing the risk of lactic acidosis. Caution and monitoring are required.
• Digoxin: Sitagliptin may slightly increase digoxin levels, which may increase the risk of toxicity in sensitive individuals. Monitoring may be required.

Use Gemer Sita Ir 50/500/2 Tablet 10 with caution if you have:

• Heart disease: Patients with heart conditions, especially heart failure, may have an increased risk of complications such as lactic acidosis. Careful monitoring is required during treatment.
• Hypoglycaemia risk conditions: Patients with irregular eating patterns, malnutrition, or severe illness may be more prone to low blood sugar due to glimepiride. Regular meals and monitoring are important.
• Pancreatitis: Sitagliptin has been associated with cases of pancreatitis. Patients with a history of pancreatitis should take this medicine with caution and report symptoms such as severe abdominal pain immediately.
• Vitamin B12 deficiency: Long-term use of metformin may reduce vitamin B12 levels, potentially leading to anaemia or neuropathy. Periodic monitoring may be recommended.

Take Gemer Sita Ir 50/500/2 Tablet 10 exactly as prescribed by your doctor. The dose is usually individualised based on your blood glucose levels, response to treatment, and tolerance. It is typically taken with food to improve glycaemic control and reduce the risk of gastrointestinal side effects. Your doctor may adjust the dose gradually to achieve optimal blood sugar levels while minimising the risk of hypoglycaemia.

Taking more than the prescribed dose may increase the risk of serious side effects such as severe hypoglycaemia or lactic acidosis. Symptoms of hypoglycaemia may include sweating, confusion, dizziness, or weakness, while lactic acidosis may present with rapid breathing, muscle pain, or unusual fatigue. Seek immediate medical attention if an overdose is suspected.

If you miss a dose, take it as soon as you remember with food. If it is close to your next scheduled dose, skip the missed dose and continue your regular dosing schedule. Do not take two doses at the same time to make up for a missed dose, as this may increase the risk of hypoglycaemia.